XML 73 R60.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information - Summary of Operating Result Information for Each Reportable Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue    
Revenue $ 79,866 $ 81,056
Cost of goods sold    
Cost of goods sold 11,581 11,881
Gross profit    
Gross profit 68,285 69,175
Operating expense (118,817) (126,449)
Loss from operations (50,532) (57,274)
Investment income (5,917) (7,289)
Interest expense 4,662 5,408
Loss on debt extinguishment 1,962 0
Other expense, net 32 44
Loss before income taxes (51,271) (55,437)
Surgical Glaucoma    
Revenue    
Revenue 75,902 74,310
Cost of goods sold    
Cost of goods sold 9,448 8,830
Gross profit    
Gross profit 66,454 65,480
Dry Eye    
Revenue    
Revenue 3,964 6,746
Cost of goods sold    
Cost of goods sold 2,133 3,051
Gross profit    
Gross profit $ 1,831 $ 3,695